Trials / Conditions / Gestational Trophoblastic Tumor

Gestational Trophoblastic Tumor

25 registered clinical trials studyying Gestational Trophoblastic Tumor — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Asse NCT06790706	Hospices Civils de Lyon	Phase 2
Completed	The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479	Taproot Health	—
Active Not Recruiting	Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neop NCT04562558	xiang yang	N/A
Unknown	Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GT NCT03885388	Women's Hospital School Of Medicine Zhejiang University	Phase 2 / Phase 3
Active Not Recruiting	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013	National Cancer Institute (NCI)	Phase 2
Completed	Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Ca NCT02096783	University of Wisconsin, Madison	N/A
Unknown	Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestationa NCT01823315	Ding Ma	Phase 3
Terminated	Blood Samples From Patients on a Clinical Trial to CINV During HSCT NCT00900068	OHSU Knight Cancer Institute	—
Completed	Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant NCT00900406	Vanderbilt-Ingram Cancer Center	—
Terminated	T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant NCT00651716	Vanderbilt-Ingram Cancer Center	—
Completed	Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Ha NCT00410657	Fred Hutchinson Cancer Center	Phase 2
Terminated	Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant NCT00324324	OHSU Knight Cancer Institute	Phase 3
Terminated	Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor NCT00096187	Gynecologic Oncology Group	Phase 2
Completed	Campath-1H + FK506 and Methylprednisolone for GVHD NCT00109993	Case Comprehensive Cancer Center	Phase 2
Completed	Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Be NCT00293384	Barbara Ann Karmanos Cancer Institute	N/A
Completed	Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation NCT00064311	National Institutes of Health Clinical Center (CC)	Phase 1 / Phase 2
Completed	Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer NCT00058071	Gynecologic Oncology Group	Phase 3
Completed	Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients NCT00082654	Fred Hutchinson Cancer Center	N/A
Completed	Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Ly NCT00004157	Fred Hutchinson Cancer Center	Phase 2
Completed	Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, NCT00010283	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Completed	Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia NCT00003688	Gynecologic Oncology Group	Phase 2
Completed	Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transp NCT00003887	Fred Hutchinson Cancer Center	Phase 2
Completed	Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With C NCT00003408	Cancer Treatment Centers of America	Phase 2
Completed	Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors NCT00003107	Indiana University School of Medicine	Phase 1
Completed	Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442	Gynecologic Oncology Group	—